Dilated cardiomyopathy and aldosteronoma: a causal link?
ESC Heart Failure, 2020 The aim of this study is to reveal the causal relationship between dilated cardiomyopathy and aldosteronoma. A 44‐year‐old male dilated cardiomyopathy patient with aldosteronoma, who demonstrated a worse cardiac function after 1 year therapy with ...
Jiyu Zhang, Jin Yang, Yueliang Li
doaj +1 more source
Incidence rates of dilated cardiomyopathy in adult first-degree relatives versus matched controls
International Journal of Cardiology: Heart & Vasculature, 2022 Background: The incidence rates and importance of traditional risk factors in dilated cardiomyopathy among first-degree relatives are unknown. Methods and Results: We identified all probands with dilated cardiomyopathy (n = 13,714, mean age at diagnosis ...
Charlotte Andersson +10 more
doaj +1 more source
The Effect of Type 2 Diabetes Mellitus on the Prognosis of Patients with Dilated Cardiomyopathy [PDF]
Zhongguo quanke yixue, 2023 Background Type 2 diabetes mellitus increases the risk of early onset of cardiovascular disease in patients, which poses a major threat to human health. Exploring the impact of type 2 diabetes mellitus on prognosis of patients with dilated cardiomyopathy
WANG Haiyan, HUANG Yuan, GUI Chun
doaj +1 more source
Genetic modifiers of Duchenne muscular dystrophy and dilated cardiomyopathy [PDF]
, 2015 OBJECTIVE: Dilated cardiomyopathy (DCM) is a major complication and leading cause of death in Duchenne muscular dystrophy (DMD). DCM onset is variable, suggesting modifier effects of genetic or environmental factors.
Angelini, Corrado +22 more
core +7 more sources
Investigating the role of uncoupling of troponin I phosphorylation from changes in myofibrillar Ca(2+)-sensitivity in the pathogenesis of cardiomyopathy. [PDF]
, 2014 Contraction in the mammalian heart is controlled by the intracellular Ca2+ concentration as it is in all striated muscle, but the heart has an additional signalling system that comes into play to increase heart rate and cardiac output during exercise or ...
Marston, SB, Messer, AE
core +2 more sources
Metabolic and cardiac adaptation to chronic pharmacologic blockade of facilitative glucose transport in murine dilated cardiomyopathy and myocardial ischemia [PDF]
, 2018 GLUT transgenic and knockout mice have provided valuable insight into the role of facilitative glucose transporters (GLUTs) in cardiovascular and metabolic disease, but compensatory physiological changes can hinder interpretation of these models.
Heitmeier, Monique R. +6 more
core +2 more sources
Brazilian Journal of Medical and Biological Research, 2008 Cardiac interstitial fibrosis may contribute to ventricular dysfunction and the prognosis of patients with dilated cardiomyopathy. The objective of the present study was to determine if total myocardial collagen content and collagen type III/I (III/I ...
H.N. Soufen +7 more
doaj +1 more source
Selecting patients with nonischemic dilated cardiomyopathy for ICDs [PDF]
, 2017 No abstract ...
Cleland, John G.F. +2 more
core +1 more source
Molecular studies in familial dilated cardiomyopathy – A pilot study
International Journal of Cardiology: Heart & Vasculature, 2022 Aim: To study genetic variants in patients of familial dilated cardiomyopathy. Methodology: Patients with reduced ejection fraction of less than 45% and dilated left ventricle are considered to have dilated cardiomyopathy.
Vyom Mori +11 more
doaj +1 more source
Significance of myocardial tenascin-C expression in left ventricular remodelling and long-term outcome in patients with dilated cardiomyopathy [PDF]
, 2015 Aim Dilated cardiomyopathy (DCM) has a variety of causes, and no useful approach to predict left ventricular (LV) remodelling and long-term outcome has yet been established.
Anzai, T +12 more
core +1 more source